Pui-Ying Iroh Tam1, Lawrence C Madoff2, Brandon Coombes3, Stephen I Pelton4. 1. University of Minnesota Children's Hospital, Minneapolis, Minnesota; irohtam@umn.edu. 2. Massachusetts Department of Public Health, Boston, Massachusetts;University of Massachusetts Medical School, Worcester, Massachusetts; 3. Clinical and Translational Science Institute, University of Minnesota, Minneapolis, Minnesota; and. 4. Boston University Medical Center, Boston, Massachusetts.
Abstract
OBJECTIVE: To examine whether there is a different clinical profile and severity of invasive pneumococcal disease (IPD) in children caused by nonvaccine types in the era of 13-valent pneumococcal conjugate vaccine (PCV13). METHODS: Observational study of childhood IPD in Massachusetts based on state public health surveillance data comparing pre-PCV13 (2007-2009) and post-PCV13 (2010-2012) eras. RESULTS: There were 168 pre-PCV13 cases of IPD and 85 post-PCV13 cases of IPD in Massachusetts children ≤5 years of age. PCV13 serotypes declined by 18% in the first 2 years after PCV13 use (P = .011). In the post-PCV13 phase, a higher proportion of children were hospitalized (57.6% vs. 50.6%), and a higher proportion of children had comorbidity (23.5% vs. 19.6%). Neither difference was statistically significant, nor were comparisons of IPD caused by vaccine and nonvaccine types. Children with comorbidities had higher rates of IPD caused by a nonvaccine type (27.6% vs. 17.2%; P = .085), were more likely to be hospitalized (80.4% vs. 50%; P < .0001), and were more likely to have a longer hospital stay (median of 3 days vs. 0.5 days; P = .0001). CONCLUSIONS: Initial data suggest that nonvaccine serotypes are more common in children with underlying conditions, who have greater morbidity from disease. In the post-PCV13 era, a larger proportion of patients are hospitalized, but mortality rates are unchanged. Routine vaccination with PCV13 may not be enough to reduce the risk in patients with comorbidity.
OBJECTIVE: To examine whether there is a different clinical profile and severity of invasive pneumococcal disease (IPD) in children caused by nonvaccine types in the era of 13-valent pneumococcal conjugate vaccine (PCV13). METHODS: Observational study of childhood IPD in Massachusetts based on state public health surveillance data comparing pre-PCV13 (2007-2009) and post-PCV13 (2010-2012) eras. RESULTS: There were 168 pre-PCV13 cases of IPD and 85 post-PCV13 cases of IPD in Massachusetts children ≤5 years of age. PCV13 serotypes declined by 18% in the first 2 years after PCV13 use (P = .011). In the post-PCV13 phase, a higher proportion of children were hospitalized (57.6% vs. 50.6%), and a higher proportion of children had comorbidity (23.5% vs. 19.6%). Neither difference was statistically significant, nor were comparisons of IPD caused by vaccine and nonvaccine types. Children with comorbidities had higher rates of IPD caused by a nonvaccine type (27.6% vs. 17.2%; P = .085), were more likely to be hospitalized (80.4% vs. 50%; P < .0001), and were more likely to have a longer hospital stay (median of 3 days vs. 0.5 days; P = .0001). CONCLUSIONS: Initial data suggest that nonvaccine serotypes are more common in children with underlying conditions, who have greater morbidity from disease. In the post-PCV13 era, a larger proportion of patients are hospitalized, but mortality rates are unchanged. Routine vaccination with PCV13 may not be enough to reduce the risk in patients with comorbidity.
Authors: C G Whitney; M M Farley; J Hadler; L H Harrison; C Lexau; A Reingold; L Lefkowitz; P R Cieslak; M Cetron; E R Zell; J H Jorgensen; A Schuchat Journal: N Engl J Med Date: 2000-12-28 Impact factor: 91.245
Authors: Cynthia G Whitney; Monica M Farley; James Hadler; Lee H Harrison; Nancy M Bennett; Ruth Lynfield; Arthur Reingold; Paul R Cieslak; Tamara Pilishvili; Delois Jackson; Richard R Facklam; James H Jorgensen; Anne Schuchat Journal: N Engl J Med Date: 2003-05-01 Impact factor: 91.245
Authors: Rosalyn J Singleton; Thomas W Hennessy; Lisa R Bulkow; Laura L Hammitt; Tammy Zulz; Debby A Hurlburt; Jay C Butler; Karen Rudolph; Alan Parkinson Journal: JAMA Date: 2007-04-25 Impact factor: 56.272
Authors: Lauri A Hicks; Lee H Harrison; Brendan Flannery; James L Hadler; William Schaffner; Allen S Craig; Delois Jackson; Ann Thomas; Bernard Beall; Ruth Lynfield; Arthur Reingold; Monica M Farley; Cynthia G Whitney Journal: J Infect Dis Date: 2007-10-04 Impact factor: 5.226
Authors: Andrew P Steenhoff; Samir S Shah; Adam J Ratner; Sujata M Patil; Karin L McGowan Journal: Clin Infect Dis Date: 2006-02-27 Impact factor: 9.079
Authors: Daniel R Feikin; Mollie Davis; Okey C Nwanyanwu; Peter N Kazembe; Lawrence M Barat; Avril Wasas; Peter B Bloland; Charles Ziba; Thora Capper; Robin E Huebner; Ben Schwartz; Keith P Klugman; Scott F Dowell Journal: Pediatr Infect Dis J Date: 2003-06 Impact factor: 2.129
Authors: Tolulope A Adebanjo; Tracy Pondo; David Yankey; Holly A Hill; Ryan Gierke; Mirasol Apostol; Meghan Barnes; Susan Petit; Monica Farley; Lee H Harrison; Corinne Holtzman; Joan Baumbach; Nancy Bennett; Suzanne McGuire; Ann Thomas; William Schaffner; Bernard Beall; Cynthia G Whitney; Tamara Pilishvili Journal: Pediatrics Date: 2020-02-13 Impact factor: 7.124
Authors: Kedibone Ndlangisa; Mignon du Plessis; Mushal Allam; Nicole Wolter; Linda de Gouveia; Keith P Klugman; Cheryl Cohen; Rebecca A Gladstone; Anne von Gottberg Journal: J Clin Microbiol Date: 2017-12-26 Impact factor: 5.948
Authors: Annabelle de St Maurice; Carlos G Grijalva; Christopher Fonnesbeck; William Schaffner; Natasha B Halasa Journal: Pediatrics Date: 2015-10-12 Impact factor: 7.124
Authors: Eun Young Cho; Eun Hwa Choi; Jin Han Kang; Kyung-Hyo Kim; Dong Soo Kim; Yae-Jean Kim; Young Min Ahn; Byung Wook Eun; Sung Hee Oh; Sung-Ho Cha; Hye-Kyung Cho; Young Jin Hong; Kwang Nam Kim; Nam Hee Kim; Yun-Kyung Kim; Jong-Hyun Kim; Hyunju Lee; Taekjin Lee; Hwang Min Kim; Kun Song Lee; Chun Soo Kim; Su Eun Park; Young Mi Kim; Chi Eun Oh; Sang Hyuk Ma; Dae Sun Jo; Young Youn Choi; Jina Lee; Geun-Ryang Bae; Ok Park; Young-Joon Park; Eun Seong Kim; Hoan Jong Lee Journal: J Korean Med Sci Date: 2016-04-27 Impact factor: 2.153